HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Borbély, A. A. Articles by Veress, G. Search for Related Content PubMed PubMed Citation Articles by Borbély, A. A. Articles by Veress, G. Agricola Articles by Borbély, A. A. Articles by Veress, G.

Effects of human papillomavirus type 16 oncoproteins on survivin gene expression

¹ Department of Medical Microbiology, Medical and Health Science Centre, University of Debrecen, PO Box 17, H-4012 Debrecen, Hungary
² Tumourvirus Research Group of the Hungarian Academy of Sciences, PO Box 17, H-4012 Debrecen, Hungary
³ Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, NY 14263, USA

Correspondence
György Veress
veregy{at}jaguar.unideb.hu

Survivin has recently been identified as a novel member of the inhibitor of apoptosis (IAP) gene family. The product of this gene not only suppresses apoptosis but also controls cell division. Survivin is undetectable in most terminally differentiated normal tissues but is expressed in embryonic and fetal organs and is present in most malignant tumours. Human papillomaviruses (HPV) are thought to play an important role in the development of cervical cancer. By interfering in the cell cycle, the viral oncoproteins (E6 and E7) can induce the immortalization of the host cell. The transcriptional effects of the HPV-16 E6 and E7 proteins on the survivin promoter in transiently transfected cell lines using luciferase tests were examined. HPV-16 E6, but not E7, was found to significantly transactivate the survivin promoter. Experiments performed in different cancer cell lines and with different E6 mutants indicated that the effect of E6 on the survivin promoter is largely dependent on p53 status. In accordance with this, the p53 tumour suppressor protein downregulated the expression of survivin. As E6 is able to interact with p53 and induces its ubiquitin-dependent degradation, it appears that the transactivation effect of E6 on survivin is mediated by the p53 degradation pathway. Transduction of HPV-16 E6 and E7 into human embryonic fibroblast cells showed that the HPV oncoproteins can upregulate endogenous survivin mRNA. Importantly, cell cycle synchronization experiments showed that the effect of HPV-16 E6 on survivin transcription is independent of the cell cycle.

This article has been cited by other articles:

				C. A. Moody, A. Fradet-Turcotte, J. Archambault, and L. A. Laimins Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification PNAS, December 4, 2007; 104(49): 19541 - 19546. [Abstract] [Full Text] [PDF]

				A A Borbely, M Murvai, K Szarka, J Konya, L Gergely, Z Hernadi, and G Veress Survivin promoter polymorphism and cervical carcinogenesis J. Clin. Pathol., March 1, 2007; 60(3): 303 - 306. [Abstract] [Full Text] [PDF]